Navigation Links
Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
Date:5/31/2011

the non-oncology patient population under the trade name Zortress® for the prophylaxis of organ rejection in adult patients at low-moderate immunologic risk receiving a kidney transplant. In the EU, everolimus is available in different dosage strengths under the trade name Certican® for the prevention of organ rejection in heart and kidney transplant recipients.

Everolimus is exclusively licensed to Abbott and sublicensed to Boston Scientific for use in drug-eluting stents.

Not all indications are available in every country. As an investigational compound the safety and efficacy profile of everolimus has not yet been established in all countries in pancreatic or any other type of NET, or in locally-advanced or metastatic breast cancer. Access to everolimus outside of the approved indications has been carefully controlled and monitored in clinical trials designed to better understand the potential benefits and risks of the compound. Because of the uncertainty of clinical trials, there is no guarantee that everolimus will become commercially available for pancreatic or any other type of NET, locally-advanced or metastatic breast cancer or additional indications anywhere else in the world.

Important Safety Information about AFINITOR (everolimus) tablets Patients should not take AFINITOR if they are allergic to AFINITOR or to any of its ingredients. Patients should tell their healthcare provider before taking AFINITOR if they are allergic to sirolimus (Rapamune®#) or temsirolimus (Torisel®#).

AFINITOR can cause serious side effects including lung or breathing problems, infections and kidney failure, which can lead to death. If patients experience these serious side effects, they may need to stop taking AFINITOR for a while or use a lower dose. Patients should tell their healthcare provider right away if they have any of these symptoms: new or worsening cough, shortness of breath, chest pain, difficulty breathin
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... FREMONT, Calif. , July 7, 2015  The ... and Velos, Inc. have entered into a seven year ... research nationally throughout South Korea and ... signing was accompanied by a two day joint workshop between ... Korea.  National Cancer Center President Dr. Lee ...
(Date:7/7/2015)... , Kalifornien, 7. Juli 2015 /PRNewswire/ ... Medizintechnikunternehmen, das sich der Entwicklung innovativer Geräte ... heute den Zugang von R. Michael ... Herr Kleine verfügt über eine ... Medizintechnik und Gesundheitsfürsorge. Er hat verschiedene globale ...
(Date:7/7/2015)... Md. , July 7, 2015 ... (CRO) focusing in Oncology, Vaccines, and General Medicine ... the final locked database to Heron Therapeutics, Inc. ... 3 receptor antagonist product candidate SUSTOL® (granisetron ... regimen with the IV NK 1 receptor ...
Breaking Medicine Technology:National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... ALTO, Calif., Jan. 10, 2012 Varian Medical Systems (NYSE: ... a new radiotherapy treatment planning tool designed to work with ... the amount of time needed for planning advanced treatments. ... clinician must take the patient,s anatomical images and identify and ...
... Agreement allows development for potential treatment of chronic constipation ... SHPGY ), the global specialty biopharmaceutical company, announced today ... market Resolor ® (prucalopride) in the United States ... of the agreement have not been disclosed. ...
Cached Medicine Technology:Varian Medical Systems Receives FDA 510(k) Clearance for Software that Speeds Up Radiotherapy Treatment Planning 2Shire Acquires US Rights to Resolor(R) (prucalopride) 2Shire Acquires US Rights to Resolor(R) (prucalopride) 3Shire Acquires US Rights to Resolor(R) (prucalopride) 4
(Date:7/7/2015)... ... July 07, 2015 , ... ... announces the IV Tube Holder, a medical invention that prevents IV lines from ... in the world which will be worth $133 billion by 2016," says Scott ...
(Date:7/7/2015)... ... July 07, 2015 , ... An ... Consultants that discussed how innovation and technology would be the “key factors” in ... address issues of accessibility and affordability, especially in emerging and growing markets. According ...
(Date:7/7/2015)... ... July 07, 2015 , ... sweetFrog Enterprises has announced ... and provide frozen yogurt offerings at Live Nation's amphitheaters in Virginia Beach and ... site at concerts throughout the summer and brand ambassadors will offer free t-shirts ...
(Date:7/7/2015)... ... 07, 2015 , ... WiseWear®, a wearable startup that specializes ... of luxury smart jewelry called the Socialite™ collection. The product line is available ... , “The Socialite collection was crafted to inspire women to be safe, mindful ...
(Date:7/7/2015)... ... ... Owners of Green Ladies Cleaning are very pleased to announce that they are ... only be gained by votes from Madison Magazine readership. , The company says that ... use daily. Having a home cleaned with all-natural products means that residents of apartments, ...
Breaking Medicine News(10 mins):Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 3Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 4Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 5Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:sweetFrog Mobile Trucks to Offer Froyo at Live Nation Venues 2Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2
... Whiteboard to improve the level of patient care and streamline workflow ... makes this announcement from the 2009 Annual HIMSS Conference & Exhibition ... number 2468. , ... Chicago, IL (PRWEB) April 6, ...
... 6 Today, Craneware, Inc. (AIM: CRW.L), the ... solutions, announced an agreement with Premier ... unit of Premier Inc. Under the agreement, ... terms for Craneware financial performance software and services ...
... study uses hormone-antioxidant combo to improve odds of conception ... A hormone-antioxidant combination therapy appears to improve sperm count ... study. , The research included 60 men eligible ... either the combination treatment of clomiphene citrate and vitamin ...
... Integration and Interoperability Costs and Improve Continuation of ... Inc. (IGI) today announced the launch of the ... provides an efficient way to exchange healthcare information ... solution will allow healthcare providers to be more ...
... Security of Personal Health Information Still Major Concern ... determine how they will take advantage of the ... help jumpstart advances in health information technology (HIT), ... tools and services is also growing, according to ...
... Pharma today announced the formation of its Scientific Advisory Board, ... assist the company in the design and execution of its ... (NO) and redox biology. Dr. Joseph Loscalzo, Chairman of ... Hersey Professor of the Theory and Practice of Medicine at ...
Cached Medicine News:Health News:Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status 2Health News:Orion Health Concerto Whiteboard Helps Emergency Rooms and Wards Track Patient Status 3Health News:Craneware to Offer Financial Performance Solutions to Hospitals and Healthcare Providers Through Premier, the Largest U.S. Healthcare Alliance 2Health News:Craneware to Offer Financial Performance Solutions to Hospitals and Healthcare Providers Through Premier, the Largest U.S. Healthcare Alliance 3Health News:Male Infertility Treatment Boosts Sperm Count 2Health News:IGI Announces Portal Designed to Maximize Data Sharing Between Hospitals and Their Affiliated Physicians 2Health News:IGI Announces Portal Designed to Maximize Data Sharing Between Hospitals and Their Affiliated Physicians 3Health News:Deloitte Survey Finds Healthy Consumer Demand For Electronic Health Records, Online Tools and Services 2Health News:Deloitte Survey Finds Healthy Consumer Demand For Electronic Health Records, Online Tools and Services 3Health News:Deloitte Survey Finds Healthy Consumer Demand For Electronic Health Records, Online Tools and Services 4Health News:Deloitte Survey Finds Healthy Consumer Demand For Electronic Health Records, Online Tools and Services 5Health News:N30 Pharma Forms Scientific Advisory Board 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: